Pancreatic Cancer Research

ResearcherUniversity of Colorado AnschutzNo recent work listed

Ayman J. Oweida

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1256-4893; OpenAlex author ID A5037683480. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2021: 2 papers

Papers 2

  1. Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleoti… Co-author DOI 10.1007/s00262-020-02701-w↗
  2. Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-20-3892↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael James Gough · 2 shared papers, 2021 · strength 0.19
  2. Karyn A. Goodman · 2 shared papers, 2021 · strength 0.19
  3. Miles Piper · 2 shared papers, 2021 · strength 0.19
  4. Sana D. Karam · 2 shared papers, 2021 · strength 0.19
  5. Adam Christopher Mueller · 2 shared papers, 2021 · strength 0.19
  6. Marco Del Chiaro · 2 shared papers, 2021 · strength 0.19
  7. Richard David Schulick · 2 shared papers, 2021 · strength 0.19
  8. Kirk Charles Hansen · 2 shared papers, 2021 · strength 0.19
  9. Wells A. Messersmith · 2 shared papers, 2021 · strength 0.19
  10. Martin D. McCarter · 1 shared paper, 2021 · strength 0.09
  11. Sara Zakem · 1 shared paper, 2021 · strength 0.09
  12. David Lagares · 1 shared paper, 2021 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.